• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ASCO President Dr Peter Yu Discusses Aggregating Patient, Doctor Data

Video

The move toward an age of digital health will allow doctors to learn more and faster when it comes to drug toxicity and side effects, according to Peter P. Yu, MD, FASCO, 2014-2015 ASCO president.

The move toward an age of digital health will allow doctors to learn more and faster when it comes to drug toxicity and side effects, according to Peter P. Yu, MD, FASCO, 2014-2015 ASCO president and director of cancer research at the Palo Alto Medical Foundation.

Dr Yu will serve as a keynote speaker for The American Journal of Managed Care's 3rd annual "Patient-Centered Oncology Care" meeting on November 13-14 in Baltimore, MD

He outlined the use of ASCO’s health IT platform, CancerLinQ, which will collect data across hundreds of providers and thousands of patients and avoid the bias that can be present in small sample sizes.

“CancerLinQ will allow us to amass this data, aggregate it and analyze it, and then learn from that,” Dr Yu explained. “If that is then married to clinical decision support, so that information is returned to the doctor at the point of care, it will allow the physician to more rapidly consider choices and make better treatment decisions.”

Related Videos
Leslie Fish, PharmD.
Ronesh Sinha, MD
Adam Colborn, JD
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Yuqian Liu, PharmD
Jenny Craven, PharmaD, BCPS
Kimberly Westrich, MA
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Sarah Bajorek, PhD, BCACP, MBA.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.